Pierrel Pharma S.r.l. received recognition from the Edison Awards™, a prestigious organization known for acknowledging innovation, creativity, and ingenuity in the global economy, for its advanced, early oral cancer screening device: Goccles®.
The US Food and Drug Administration-approved medical device is used in combination with traditional examination to help identify early signs of oral cancer. The eyewear utilizes a patented optical filter with a standard curing light, exposing the fluorescence of healthy mucosa and potentially suspicious pre-cancerous and cancerous lesions. With Goccles, there is no need to purchase additional consumables for use and its price point is relatively low in comparison to similar devices. Goccles is supported by clinical studies and has received an excellent clinical evaluation from Dental Advisor.
Goccles was launched in the US in 2018, and is available through all major distributors, including Patterson Dental, Henry Schein, Benco Dental, and Darby Dental.